1.Alopecia and Treatment.
Journal of the Korean Medical Association 1999;42(7):681-690
No abstract available.
Alopecia*
2.The Association between Exercise and Androgenetic Alopecia: A Survey-Based Study.
Jaewoong CHOI ; Myungsoo JUN ; Solam LEE ; Sung Soo OH ; Won Soo LEE
Annals of Dermatology 2017;29(4):513-516
No abstract available.
Alopecia*
3.A Case of Congenital Triangular Alopecia.
Hyoung Cheol YOO ; Seong Jin KIM ; Seung Chul LEE ; Young Ho WON
Korean Journal of Dermatology 2000;38(5):710-711
No Abstract Available.
Alopecia*
4.A Case of Transient Rectangular Alopecia after Neurovascular Embolization.
Soon Hyo KWON ; Sun Jae NA ; Sang Young BYUN ; Hyun Sun PARK ; Hyun Sun YOON ; Soyun CHO
Korean Journal of Dermatology 2013;51(7):566-568
No abstract available.
Alopecia
5.A clinical study for alopecia areata(II).
Tae Jin CHUN ; Chang Kwun HONG ; Byung In RO
Korean Journal of Dermatology 1991;29(6):765-773
No abstract available.
Alopecia*
6.Efficacy and safety of topical Adenosine for Androgenetic Alopecia in adults: A systematic review
Blythe N. Ke ; Juan Paolo David S. Villena ; Ma. Lorna F. Frez
Acta Medica Philippina 2020;54(3):320-326
Background:
Androgenetic alopecia (AGA), also known as pattern hair loss, is the most common type of hair loss in men and women. Due to very limited therapeutic options, search for other effective and safe drugs is necessary.
Objectives:
This review aims to evaluate the efficacy and safety of a potential treatment option, topical adenosine, for AGA in male and female adults.
Methods:
A search of databases (Cochrane Library, Pubmed Medline, and others) was performed with no time limitations placed. We included human interventional studies published in English involving the use of topical adenosine for AGA in healthy adult males and females. Risk bias assessment was performed using the Cochrane Collaboration criteria.
Results:
All four trials in this review, with a total of 260 participants, used 0.75% topical adenosine lotion twice a day for a period of 6-12 months. Comparators were placebo, topical niacinamide, and topical minoxidil. Evaluated parameters include improvement in baldness grading as assessed by dermatologists and investigators, improvement and satisfaction as assessed by participants, anagen growth, thick/thin/vellus hair ratio, and hair density. Two trials found significant improvement with thick hair ratio (>60 or >80 μm) with the use of topical adenosine while two trials showed higher overall participant satisfaction with topical adenosine. Few to no adverse effects were reported with its use.
Conclusion
This is the first systematic review involving topical adenosine for AGA. Topical adenosine may be effective in increasing thick hair ratio and improving the self-perception of hair growth. With minimal to no adverse effects, it may serve as an adjunct or alternative to present treatment options. However, more studies are needed to strengthen these findings.
Alopecia
7.Histopathologic findings of normal scalp and alopecia areata in transverse sections.
Korean Journal of Dermatology 1991;29(4):506-513
No abstract available.
Alopecia Areata*
;
Alopecia*
;
Scalp*
8.Treatment of alopecia areata.
Korean Journal of Dermatology 2005;43(10):1309-1315
No abstract available.
Alopecia Areata*
;
Alopecia*
9.Analysis of Personality Trait in Patients with Alopecia Areata.
Jeong Min KIM ; Hoon Soo KIM ; Hyun Chang KO ; Byung Soo KIM ; Moon Bum KIM
Annals of Dermatology 2017;29(6):815-816
No abstract available.
Alopecia Areata*
;
Alopecia*
;
Humans
10.Efficacy of Oral Tofacitinib in Patients with Alopecia Areata: Tofacitinib Was Ineffective for Recalcitrant Alopecia Totalis of a Long Duration
Yong Yon WON ; Bark Lynn LEW ; Woo Young SIM
Korean Journal of Dermatology 2019;57(5):298-300
No abstract available.
Alopecia Areata
;
Alopecia
;
Humans
Result Analysis
Print
Save
E-mail